Panel of Experts
Panel of
Experts
Dr. Cheryl Anne A. Dela Cruz – Tan
Education
March 2013-February 2015: Fellowship training in Rheumatology, Clinical Immunology and Osteoporosis UST
Occupational Medicine (PCOM)
January 2006-December 2009: Internal Medicine Residency Training, Southern Philippines Medical Center
Years of experience
6 years of experience
Specializations
Member, International Society of Clinical Densitometry
Diplomate, Philippine Rheumatology Association
Member, Osteoporosis Society of the Philippines
Member, Philippine Rheumatology Association
Fellow, Philippine College of Physicians
Member, Philippine College of Occupational Medicine
Member, Philippine Medical Association
Member, Davao Medical Society
Memberships
Member, International Society of Clinical Densitometry
Diplomate, Philippine Rheumatology Association
Member, Osteoporosis Society of the Philippines
Member, Philippine Rheumatology Association
Fellow, Philippine College of Physicians
Member, Philippine College of Occupational Medicine
Member, Philippine Medical Association
Member, Davao Medical Society
Experience (Duration & Current working place)
Full-time Faculty – Brokenshire College School of Medicine (2019-present)
Section Head of the Physiology Department Laboratory – Brokenshire College School of Medicine (2016-2019)
Third and Fourth Year Overall Coordinator – Brokenshire College School of Medicine (2018-present)
First Year Level Coordinator – Department of Internal Medicine, Southern Philippines Medical Center (2016-2019)
Training Officer – Department of Internal Medicine, Southern Philippines Medical Center (Jan 2020 – Dec 2022)
Extracurricular activities
A Phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus eryhematosus (BLISS) – Study Coordinator
Aurinia Renal Response in Active Lupus with Voclosporine (Aurora) – Sub-investigator; Southern Philippines Medical Center
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Ertythematosus (SLE) (LILAC) – Sub-investigator; Southern Philippines Medical Center
A Double Blind, Randomized, Placebo-Controlled Trial Evaluating the Effect of BI 655064 Administered as Subcutaneous Injections on Renal Response after One Year of Treatment in Patients with Active Lupus Nephritis
Speaker for MSD – Arcoxia, 2016
Speaker for Pfizer – Celebrex (PRECISION TRIAL), 2017-2021
Speaker for Eli Lilly – Baricitinib (OLUMIANT), 2020
